Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5c81a01c66bc0e51e95841c0e64aee4 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4245 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4245 |
filingDate |
2003-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6c7b8463f713bb58f3051e3671984c4 |
publicationDate |
2007-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2007224671-A1 |
titleOfInvention |
Inhibitors of serine protease activity methods and compositions for treatment of nitric oxide-induced clinical conditions |
abstract |
A novel method of treating and preventing diseases is provided. In particular, compositions and methods of blocking diseases associated with aberrant levels of nitric oxide and facilitated by a serine proteolytic (SP) activity are disclosed, which consist of administering to a subject a therapeutically effective amount of a compound having a serine protease inhibitory activity. Among effective compounds are α 1 -antitrypsin and synthetic drugs mimicking some or all of the actions of α 1 -antitrypsin. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011237496-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7985776-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7906643-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009326275-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7723515-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7745670-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009325963-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010029537-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8383865-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011130392-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010190978-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8288444-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8350093-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010292512-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8609652-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010087527-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010286585-A1 |
priorityDate |
2003-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |